Avmapki Fakzynja Co-Pack (avutometinib capsules; defactinib tablets) — Medica
Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Initial criteria
- age ≥ 18 years
- recurrent low-grade serous cancer
- cancer has a KRAS mutation
- patient has tried at least one systemic therapy (e.g., paclitaxel, carboplatin, bevacizumab, letrozole, anastrozole, or exemestane)
Approval duration
1 year